$543.40
-6.70-1.22%
最終更新: Oct 13, 7:30 PM
$545.10
-5.00-0.91%
Benzinga
Benzinga
Benzinga
水曜日, 10 14
Benzinga
© 2026 Benzinga | All Rights Reserved
United Therapeutics (UTHR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.86 | $6.83 | $6.77 | $6.93 |
| Actual | $7.27 | $5.82 | $7.70 | $7.16 |
| Surprise | +5.98% | -14.8% | +13.7% | +3.32% |
| Revenue | ||||
| Estimate | $807.0M | $798.0M | $808.9M | $814.8M |
| Actual | $783.3M | $781.5M | $790.2M | $799.5M |
| Surprise | -2.94% | -2.06% | -2.32% | -1.88% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $6.22 | $6.89 | $7.33 | $5.90 |
| Revenue | ||||
| Consensus | $784.3M | $808.1M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $7.27 | $6.86 | 5.98 % |
| Q1 | May 6, 2026 | $5.82 | $6.83 | -14.8 % |
| Q4 | Feb 25, 2026 | $7.70 | $6.77 | 13.7 % |
| Q3 | Oct 29, 2025 | $7.16 | $6.93 | 3.32 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $783.30M | $807.00M | -2.94 % |
| Q1 | May 6, 2026 | $781.50M | $797.97M | -2.06 % |
| Q4 | Feb 25, 2026 | $790.20M | $808.93M | -2.32 % |
| Q3 | Oct 29, 2025 | $799.50M | $814.84M | -1.88 % |